1. Home
  2. HUN vs QURE Comparison

HUN vs QURE Comparison

Compare HUN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$10.09

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$24.90

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
QURE
Founded
1970
1998
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2005
2007

Fundamental Metrics

Financial Performance
Metric
HUN
QURE
Price
$10.09
$24.90
Analyst Decision
Hold
Strong Buy
Analyst Count
11
12
Target Price
$10.23
$58.55
AVG Volume (30 Days)
5.5M
3.1M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
3.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,780,000,000.00
$15,751,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.40
$158.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.30
$7.76
52 Week High
$18.53
$71.50

Technical Indicators

Market Signals
Indicator
HUN
QURE
Relative Strength Index (RSI) 54.52 43.09
Support Level $9.82 $19.29
Resistance Level $10.40 $25.75
Average True Range (ATR) 0.52 1.76
MACD -0.06 1.03
Stochastic Oscillator 25.00 71.69

Price Performance

Historical Comparison
HUN
QURE

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: